Add-on or switch to vibegron in patients with overactive bladder insufficiently responding to initial 4-week antimuscarinics: a randomised, parallel-group, multicentre trial (ADVISR) protocol
对于初始4周抗胆碱能药物治疗效果不佳的膀胱过度活动症患者,加用或换用维贝格隆:一项随机、平行组、多中心试验(ADVISR)方案
期刊:BMJ Open
影响因子:2.3
doi:10.1136/bmjopen-2024-094230
Yamamoto, Takanobu; Yoshida, Soichiro; Maezawa, Yuya; Tamiya, Takashi; Toide, Masahiro; Fukushima, Hiroshi; Uehara, Sho; Araki, Saori; Ito, Masaya; Kobayashi, Shuichiro; Yoshinaga, Atsushi; Kawamura, Naoko; Takazawa, Ryoji; Sakai, Yasuyuki; Ootsuka, Yukihiro; Tsukamoto, Tetsuro; Nagahama, Katsushi; Tanaka, Hajime; Kitabayashi, Ryo; Hanazawa, Ryoichi; Ishiguro, Megumi; Sato, Hiroyuki; Koike, Ryuji; Fujii, Yasuhisa